SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH M impact

Rhythm Pharmaceuticals Q3 Net Loss Narrows 22% to $41.37 Million

RYTM
SquawkNews Desk 5 updates Updated Nov 03, 2026, 12:20 PM UTC

Story updates

12:09:59 PM UTC
SquawkNews
Rhythm Pharmaceuticals reduce pérdida neta del tercer trimestre de 2026 un 22% interanual, a 41,37 m
12:11:12 PM UTC
SquawkNews
Rhythm Pharmaceuticals: Nettoverlust im dritten Quartal 2026 sinkt zum Vorjahr um 22 Prozent auf 41.
12:11:43 PM UTC
SquawkNews
*-- Earnings Flash (RYTM) Rhythm Pharmaceuticals Posts Q3 Net Loss $0.61 a Share, vs. FactSet Est of $0.69 Loss
12:12:44 PM UTC
SquawkNews
RHYTHM PHARMACEUTICALS REPORTS Q3 NET LOSS PER SHARE -$0.61
12:20:11 PM UTC
SquawkNews
Rhythm Pharma Q3 net loss narrower than estimated on IMCIVREE demand Overview Biopharmaceutical firm

Related stories

Pinnacle West Capital Reports Third-Quarter Revenue of $1.97B M impact | EQUITY | Nov 03, 2026, 01:29 PM UTC Icahn Enterprises Reports Q3 2026 Net Loss of $225 Million Icahn Enterprises swung to a net loss in Q3 2026 from a profit a year earlier. M impact | EQUITY | Nov 03, 2026, 01:18 PM UTC IDEAYA Reports Q3 2026 Net Loss of $125.7 Million IDEAYA reported $10.2 million in collaboration revenue and ended September with $1.15 billion in cash, cash equivalents and marketable securities. It maintained its cash runway gui M impact | EQUITY | Nov 03, 2026, 01:17 PM UTC Anavex Appoints Terrie Kellmeyer CEO, President and Director Anavex appointed Terrie Kellmeyer to its board, effective immediately. M impact | EQUITY | Nov 03, 2026, 01:17 PM UTC Hagerty Q3 Adjusted Earnings Rise, Revenue Falls Hagerty reported higher adjusted earnings and lower revenue for Q3. M impact | EQUITY | Nov 03, 2026, 01:17 PM UTC Cadeler plc acquires 355,404,839 Cadeler A/S shares in exchange offer M impact | EQUITY | Nov 03, 2026, 01:17 PM UTC